ArticleNutrients2023

Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1.

Jankiben R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.